1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Transdermal Skin Patches Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Transdermal Skin Patches Market Analysis and Forecast, 2017 – 2031
4.4.1. Market Revenue Projection (US$ Bn)
5. Key Insights
5.1. Regulatory Scenario by Region/Globally
5.2. Disease Prevalence & Incidence Rate Globally with Key Countries
5.3. Pipeline Analysis
5.4. Key Product/brand Analysis
5.5. COVID-19 Impact on the Industry
6. Global Transdermal Skin Patches Market Analysis and Forecast, By Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Product Type, 2017 – 2031
6.3.1. Reservoir
6.3.2. Drug-in-Adhesive
6.3.2.1. Single Layer
6.3.2.2. Multilayer
6.3.3. Microneedle
6.3.4. Matrix
6.3.5. Others (Vapor, etc.)
6.4. Market Attractiveness By Product Type
7. Global Transdermal Skin Patches Market Analysis and Forecast, By Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Application, 2017 – 2031
7.3.1. Pain Management
7.3.2. Hormonal Disorders
7.3.3. Smoking Reduction and Cessation Aid
7.3.4. Neurological Disorders
7.3.5. Cardiovascular Disorders
7.3.6. Others (Motion Sickness, Overactive Bladder, etc.)
7.4. Market Attractiveness By Application
8. Global Transdermal Skin Patches Market Analysis and Forecast, By Sales Type
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By Sales Type, 2017 – 2031
8.3.1. Prescription
8.3.2. Over-the-Counter (OTC)
8.4. Market Attractiveness By Sales Type
9. Global Transdermal Skin Patches Market Analysis and Forecast, By Distribution Channel
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast By Distribution Channel, 2017 – 2031
9.3.1. Hospital Pharmacies
9.3.2. Retail Pharmacies
9.3.3. Online Pharmacies
9.4. Market Attractiveness By Distribution Channel
10. Global Transdermal Skin Patches Market Analysis and Forecast, By Region
10.1. Key Findings
10.2. Market Value Forecast By Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness By Country/Region
11. North America Transdermal Skin Patches Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Product Type, 2017 – 2031
11.2.1. Reservoir
11.2.2. Drug-in-Adhesive
11.2.2.1. Single Layer
11.2.2.2. Multilayer
11.2.3. Microneedle
11.2.4. Matrix
11.2.5. Others (Vapor, etc.)
11.3. Market Value Forecast By Application, 2017 – 2031
11.3.1. Pain Management
11.3.2. Hormonal Disorders
11.3.3. Smoking Reduction and Cessation Aid
11.3.4. Neurological Disorders
11.3.5. Cardiovascular Disorders
11.3.6. Others (Motion Sickness, Overactive Bladder, etc.)
11.4. Market Value Forecast By Sales Type, 2017 – 2031
11.4.1. Prescription
11.4.2. Over-the-Counter (OTC)
11.5. Market Value Forecast By Distribution Channel, 2017 – 2031
11.5.1. Hospital Pharmacies
11.5.2. Retail Pharmacies
11.5.3. Online Pharmacies
11.6. Market Value Forecast By Country, 2017 – 2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Product Type
11.7.2. By Application
11.7.3. By Sales Type
11.7.4. By Distribution Channel
11.7.5. By Country
12. Europe Transdermal Skin Patches Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Product Type, 2017 – 2031
12.2.1. Reservoir
12.2.2. Drug-in-Adhesive
12.2.2.1. Single Layer
12.2.2.2. Multilayer
12.2.3. Microneedle
12.2.4. Matrix
12.2.5. Others (Vapor, etc.)
12.3. Market Value Forecast By Application, 2017 – 2031
12.3.1. Pain Management
12.3.2. Hormonal Disorders
12.3.3. Smoking Reduction and Cessation Aid
12.3.4. Neurological Disorders
12.3.5. Cardiovascular Disorders
12.3.6. Others (Motion Sickness, Overactive Bladder, etc.)
12.4. Market Value Forecast By Sales Type, 2017 – 2031
12.4.1. Prescription
12.4.2. Over-the-Counter (OTC)
12.5. Market Value Forecast By Distribution Channel, 2017 – 2031
12.5.1. Hospital Pharmacies
12.5.2. Retail Pharmacies
12.5.3. Online Pharmacies
12.6. Market Value Forecast By Country, 2017 – 2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Product Type
12.7.2. By Application
12.7.3. By Sales Type
12.7.4. By Distribution Channel
12.7.5. By Country
13. Asia Pacific Transdermal Skin Patches Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Product Type, 2017 – 2031
13.2.1. Reservoir
13.2.2. Drug-in-Adhesive
13.2.2.1. Single Layer
13.2.2.2. Multilayer
13.2.3. Microneedle
13.2.4. Matrix
13.2.5. Others (Vapor, etc.)
13.3. Market Value Forecast By Application, 2017 – 2031
13.3.1. Pain Management
13.3.2. Hormonal Disorders
13.3.3. Smoking Reduction and Cessation Aid
13.3.4. Neurological Disorders
13.3.5. Cardiovascular Disorders
13.3.6. Others (Motion Sickness, Overactive Bladder, etc.)
13.4. Market Value Forecast By Sales Type, 2017 – 2031
13.4.1. Prescription
13.4.2. Over-the-Counter (OTC)
13.5. Market Value Forecast By Distribution Channel, 2017 – 2031
13.5.1. Hospital Pharmacies
13.5.2. Retail Pharmacies
13.5.3. Online Pharmacies
13.6. Market Value Forecast By Country, 2017 – 2031
13.6.1. Japan
13.6.2. China
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Product Type
13.7.2. By Application
13.7.3. By Sales Type
13.7.4. By Distribution Channel
13.7.5. By Country
14. Latin America Transdermal Skin Patches Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Product Type, 2017 – 2031
14.2.1. Reservoir
14.2.2. Drug-in-Adhesive
14.2.2.1. Single Layer
14.2.2.2. Multilayer
14.2.3. Microneedle
14.2.4. Matrix
14.2.5. Others (Vapor, etc.)
14.3. Market Value Forecast By Application, 2017 – 2031
14.3.1. Pain Management
14.3.2. Hormonal Disorders
14.3.3. Smoking Reduction and Cessation Aid
14.3.4. Neurological Disorders
14.3.5. Cardiovascular Disorders
14.3.6. Others (Motion Sickness, Overactive Bladder, etc.)
14.4. Market Value Forecast By Sales Type, 2017 – 2031
14.4.1. Prescription
14.4.2. Over-the-Counter (OTC)
14.5. Market Value Forecast By Distribution Channel, 2017 – 2031
14.5.1. Hospital Pharmacies
14.5.2. Retail Pharmacies
14.5.3. Online Pharmacies
14.6. Market Value Forecast By Country, 2017 – 2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Product Type
14.7.2. By Application
14.7.3. By Sales Type
14.7.4. By Distribution Channel
14.7.5. By Country
15. Middle East & Africa Transdermal Skin Patches Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast By Product Type, 2017 – 2031
15.2.1. Reservoir
15.2.2. Drug-in-Adhesive
15.2.2.1. Single Layer
15.2.2.2. Multilayer
15.2.3. Microneedle
15.2.4. Matrix
15.2.5. Others (Vapor, etc.)
15.3. Market Value Forecast By Application, 2017 – 2031
15.3.1. Pain Management
15.3.2. Hormonal Disorders
15.3.3. Smoking Reduction and Cessation Aid
15.3.4. Neurological Disorders
15.3.5. Cardiovascular Disorders
15.3.6. Others (Motion Sickness, Overactive Bladder, etc.)
15.4. Market Value Forecast By Sales Type, 2017 – 2031
15.4.1. Prescription
15.4.2. Over-the-Counter (OTC)
15.5. Market Value Forecast By Distribution Channel, 2017 – 2031
15.5.1. Hospital Pharmacies
15.5.2. Retail Pharmacies
15.5.3. Online Pharmacies
15.6. Market Value Forecast By Country, 2017 – 2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of the Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Product Type
15.7.2. By Application
15.7.3. By Sales Type
15.7.4. By Distribution Channel
15.7.5. By Country
16. Competition Landscape
16.1. Market Player – Competition Matrix (By Tier and Size of companies)
16.2. Market Share Analysis By Company (2022)
16.3. Company Profiles
16.3.1. Hisamitsu Pharmaceutical Co., Inc.
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Viatris Inc.
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Nitto Denko Corporation
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Novartis AG
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Luye Pharma Group
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Teikoku Pharma
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Samyang Holdings Corporation
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Gedeon Richter PLC
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. AdhexPharma
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. Sparsha Pharma International Pvt. Ltd.
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview
Table 1. Global Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Product Type, 2017-2031
Table 2. Global Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Application, 2017-2031
Table 3. Global Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Sales Type, 2017-2031
Table 4. Global Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Distribution Channel, 2017-2031
Table 5. Global Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Region, 2017-2031
Table 6. North America Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Product Type, 2017-2031
Table 7. North America Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Application, 2017-2031
Table 8. North America Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Sales Type, 2017-2031
Table 9. North America Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Distribution Channel, 2017-2031
Table 10. North America Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Region, 2017-2031
Table 11. Europe Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Product Type, 2017-2031
Table 12. Europe Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Application, 2017-2031
Table 13. Europe Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Sales Type, 2017-2031
Table 14. Europe Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Distribution Channel, 2017-2031
Table 15. Europe Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Region, 2017-2031
Table 16. Asia Pacific Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Product Type, 2017-2031
Table 17. Asia Pacific Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Application, 2017-2031
Table 18. Asia Pacific Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Sales Type, 2017-2031
Table 19. Asia Pacific Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Distribution Channel, 2017-2031
Table 20. Asia Pacific Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Region, 2017-2031
Table 21. Latin America Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Product Type, 2017-2031
Table 22. Latin America Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Application, 2017-2031
Table 23. Latin America Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Sales Type, 2017-2031
Table 24. Latin America Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Distribution Channel, 2017-2031
Table 25. Latin America Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Region, 2017-2031
Table 26. Middle East & Africa Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Product Type, 2017-2031
Table 27. Middle East & Africa Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Application, 2017-2031
Table 28. Middle East & Africa Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Sales Type, 2017-2031
Table 29. Middle East & Africa Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Distribution Channel, 2017-2031
Table 30. Middle East & Africa Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Region, 2017-2031